Kyverna Therapeutics, Inc (NASDAQ:KYTX) IPO will take place February, 08 on the NASDAQ exchange under the ticker KYTX.

The company is offering shares at an expected price between $20.00 and $21.00 per share with an insider lock-up period of 180 days ending on August 06, 2024.

See also: Benzinga IPO Calendar

About Kyverna Therapeutics, Inc

Kyverna Therapeutics, Inc is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.